Read more news
Graham Mullis
Chief Executive Officer
Graham has worked in Healthcare markets for over 25 years and held executive positions at FTSE and Nasdaq listed medical device companies including 1-800 Contacts Inc and Biocompatibles International PLC and pharmaceutical roles at Hoechst Roussel Ltd and R P Scherer Ltd. He has considerable experience in successfully launching new businesses and technologies into healthcare markets, with IPO and extensive M&A experience at a variety of medical and pharmaceutical companies.
Graham joins Lab21 from Optivue LLP, a company formed to develop and license pharmaceutical & medical device applications in optical products, where he is a co-founder. He has a degree in Biochemistry & Physiology from Southampton University and an MBA from Warwick Business School.